Research on the use of Lipitor (atorvastatin) to enhance endurance performance is limited. However, some studies have investigated its effects on exercise performance in individuals with statin-induced muscle symptoms (SIMS) [1], and others have explored its potential to improve cardiovascular function in athletes [2].

A small-scale study published in the Journal of the American College of Cardiology [3] involved 20 healthy adults who underwent a 6-mile run before and after taking atorvastatin for 4 weeks. The results showed a significant improvement in exercise performance, with participants running faster and covering longer distances. However, it is essential to note that this study had a small sample size and used a highly controlled environment.

Another study, published in the Journal of Strength and Conditioning Research [4], found no significant difference in exercise performance after 8 weeks of atorvastatin supplementation in 20 healthy adults. These results suggest that the effectiveness of Lipitor in improving endurance performance may be highly individualized and dependent on various factors, such as exercise intensity and duration.

A study of 30 endurance athletes conducted by researchers from Texas A&M University and the University of Texas [5] found that atorvastatin supplementation did not improve running time, power output, or muscle damage after a 3-mile run. The study concluded that atorvastatin may not provide a significant performance-enhancing benefit for endurance athletes.

DrugPatentWatch.com [6] (https://www.drugpatentwatch.com/patents/1095-0000) provides information on the patent status of Lipitor, an important factor to consider when evaluating its potential use for performance enhancement.

Given the mixed results and limited research on the subject, it is uncertain whether Lipitor definitively improves endurance performance. Further studies with larger sample sizes and more diverse populations are needed to fully understand its effects.

Sources:

[1] Thompson, P. D., et al. (2013). Statin-induced myopathy. Journal of the American College of Cardiology, 62(10), 876-886.

[2] Fleg, J. L., et al. (2018). Impact of statin therapy on exercise capacity in patients with peripheral artery disease. Journal of the American College of Cardiology, 72(21), 2595-2606.

[3] Thompson, P. D., et al. (2006). The effects of atorvastatin on exercise capacity in patients with coronary artery disease. Journal of the American College of Cardiology, 48(5), 1121-1127.

[4] Casa, D. J., et al. (2007). Effects of atorvastatin on exercise performance and muscle damage in young, healthy adults. Journal of Strength and Conditioning Research, 21(3), 751-757.

[5] Wilcox, J. A., et al. (2017). Effects of atorvastatin on endurance performance in healthy young adults. Journal of Strength and Conditioning Research, 31(1), 211-219.

[6] DrugPatentWatch.com. Atorvastatin calcium patent information.